DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 54 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $37,217,000 | -31.4% | 3,481,471 | -2.1% | 3.02% | -14.3% |
| Q3 2018 | $54,275,000 | +23.0% | 3,556,669 | -1.2% | 3.53% | +8.1% |
| Q2 2018 | $44,112,000 | +28.1% | 3,600,954 | 0.0% | 3.26% | +27.2% |
| Q1 2018 | $34,425,000 | +4.3% | 3,600,954 | -1.5% | 2.57% | -25.8% |
| Q4 2017 | $33,020,000 | +1542.0% | 3,656,669 | +1392.5% | 3.46% | +976.6% |
| Q3 2015 | $2,011,000 | -41.2% | 245,000 | 0.0% | 0.32% | -29.3% |
| Q2 2015 | $3,418,000 | -16.3% | 245,000 | +44.1% | 0.45% | -28.1% |
| Q1 2015 | $4,085,000 | +24.0% | 170,000 | -15.0% | 0.63% | +24.2% |
| Q4 2014 | $3,294,000 | – | 200,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |